Company | Name | Exchange | Sector | Industry | Market Cap | P/E Ratio | PEG Ratio | Last Trade Price | Day Change (%) | Fair Value | Fair Value Upside | Fair Value Label | Analyst Price Target | Analyst Target Upside | Overall Health |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Orion Oyj B | Helsinki | Healthcare | Pharmaceuticals | €7.61B | 22.6x | 0.43 | €54.14 | 2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 15% Upside | Upgrade to Pro+ | |
Orion Oyj A | Helsinki | Healthcare | Pharmaceuticals | €7.52B | 22.9x | 0.43 | €53.40 | 2.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Terveystalo | Helsinki | Healthcare | Healthcare Providers & Services | €1.45B | 20.2x | 0.07 | €11.40 | 0.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 10.9% Upside | Upgrade to Pro+ | |
Revenio Group | Helsinki | Healthcare | Healthcare Equipment & Supplies | €669.71M | 36.2x | -11.39 | €25.20 | 2.9% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 30.6% Upside | Upgrade to Pro+ | |
Pihlajalinna Oy | Helsinki | Healthcare | Healthcare Providers & Services | €292.23M | 10.7x | 0.03 | €13 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 7.7% Upside | Upgrade to Pro+ | |
Oriola-KD Oyj A | Helsinki | Healthcare | Pharmaceuticals | €217.69M | -10.3x | -2.85 | €1.21 | -0.8% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Faron Pharmaceuticals Oy | Helsinki | Healthcare | Biotechnology & Medical Research | €217.68M | -7.1x | -0.21 | €2.11 | 1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 26.8% Upside | Upgrade to Pro+ | |
Detection Technology OY | Helsinki | Healthcare | Healthcare Equipment & Supplies | €212.51M | 19.1x | 0.2 | €14.50 | -2.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 21.2% Upside | Upgrade to Pro+ | |
Oriola-KD Oyj B | Helsinki | Healthcare | Pharmaceuticals | €207.17M | -10.8x | -2.85 | €1.15 | 1.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | -5.2% Downside | Upgrade to Pro+ | |
Nightingale Health Oyj | Helsinki | Healthcare | Biotechnology & Medical Research | €161.74M | -9.4x | -2.86 | €2.78 | 3.7% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 8.2% Upside | Upgrade to Pro+ | |
Solar Foods Oyj | Helsinki | Healthcare | Biotechnology & Medical Research | €98.84M | -6.9x | 2.37 | €3.87 | 4.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | -11.1% Downside | Upgrade to Pro+ | |
Nanoform Finland Plc | Helsinki | Healthcare | Biotechnology & Medical Research | €94.94M | -3.7x | 0.61 | €1.12 | 1.1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Optomed | Helsinki | Healthcare | Healthcare Equipment & Supplies | €74.70M | -14.1x | 1.49 | €3.75 | -1.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 42.1% Upside | Upgrade to Pro+ | |
Nexstim | Helsinki | Healthcare | Healthcare Equipment & Supplies | €60.16M | -64.6x | -1.88 | €8.12 | -3.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 7.1% Upside | Upgrade to Pro+ | |
Bioretec Oy | Helsinki | Healthcare | Healthcare Equipment & Supplies | €55.54M | €2.41 | 1.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||||
Modulight Oyj | Helsinki | Healthcare | Healthcare Equipment & Supplies | €53.11M | -8x | -0.17 | €1.22 | -2.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 32% Upside | Upgrade to Pro+ | |
Herantis Pharma Oyj | Helsinki | Healthcare | Biotechnology & Medical Research | €28.33M | -5.6x | -0.48 | €1.40 | -1.8% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 32.9% Upside | Upgrade to Pro+ |